METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for METASTATIC CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a gut bug boost kidney cancer treatment?
Disease control Recruiting nowThis early-stage trial tests whether adding a live bacteria product (EXL01) to standard immunotherapy drugs (nivolumab and ipilimumab) is safe and helps control metastatic kidney cancer. About 33 adults with advanced kidney cancer that has spread will receive either the standard …
Matched conditions: METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 04:23 UTC
-
New combo therapy aims to stall advanced kidney cancer
Disease control Recruiting nowThis study tests whether adding the experimental drug casdatifan to the standard drug cabozantinib helps people with advanced clear cell kidney cancer live longer without their disease getting worse. About 720 adults whose cancer progressed after prior immunotherapy will receive …
Matched conditions: METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE3 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
Kidney cancer trial: does surgery boost immunotherapy?
Disease control Recruiting nowThis study is for people with kidney cancer that has spread to other parts of the body. It compares standard immunotherapy drugs (like nivolumab and axitinib) alone versus the same drugs plus surgery to remove the affected kidney. The goal is to see if adding surgery helps patien…
Matched conditions: METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
Fiber gel boosts cancer immunotherapy in new kidney cancer trial
Disease control Recruiting nowThis study tests whether adding a fiber supplement called inulin gel to standard immunotherapy drugs (ipilimumab and nivolumab) can help control advanced kidney cancer better than immunotherapy alone. About 55 adults with kidney cancer that has spread or is locally advanced will …
Matched conditions: METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New imaging study may unlock better kidney cancer treatments
Knowledge-focused Recruiting nowThis early-phase study looks at how the drug belzutifan changes a protein called CAIX in clear cell kidney cancer. About 12 people with advanced cancer that has worsened after immunotherapy will get belzutifan and have special PET scans before and after treatment. The goal is to …
Matched conditions: METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated May 26, 2026 04:13 UTC
-
New platform aims to predict which cancer treatments will work
Knowledge-focused Recruiting nowThis study collects tissue samples from people with various advanced or early-stage cancers to train a diagnostic platform called Elephas. The goal is to see how accurately it can predict whether a patient will respond to immunotherapy or chemoimmunotherapy. About 324 participant…
Matched conditions: METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 04:12 UTC